We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Collaboration to Promote Study of the Role of Structural Biology in Disease

By LabMedica International staff writers
Posted on 25 Jan 2012
Print article
A major manufacturer of electron microscopes has joined a cooperative research initiative to combine this method with NMR (nuclear magnetic resonance) spectroscopy and X-ray diffraction to accelerate medical discoveries in the fields of infectious diseases and cancer.

The electron microscope manufacturer FEI (Hillsboro, OR, USA) has entered into a Cooperative Research and Development Agreement (CRADA) with the [US] National Institutes of Health (Bethesda, MD, USA), to create a “Living Lab Structural Biology Center” to promote structural biology research through the integration of cryoelectron microscopy (EM), NMR spectroscopy, and X-ray diffraction (XRD).

The research program, which will be centered on the campus of the [US] National Institutes of Health, will be empowered by FEI's Titan Krios transmission electron microscope (TEM), the world's most powerful commercially-available electron microscope for structural biology.

The collaboration effort will focus on the development of methods and workflows, from sample preparation through data analysis, which combine information from cryo-EM, XRD, and NMR. Researchers have historically relied on NMR and XRD techniques to determine the structures of molecular complexes and proteins that play a role in the causes of various disease states. Structural information about a variety of medically important proteins and drugs has been obtained by NMR and XRD methods. Cryo-EM is a complementary analytical technique that provides near-atomic resolution without requirements for crystallization or limits on molecular size and complexity imposed by the other techniques.

Dr. Don Kania, president and CEO of FEI, said, “This collaborative effort with NIH is a critical part of our strategy to provide complete microscopy solutions for life science research. Our life sciences business has been increasing rapidly and is a key part of our overall corporate growth plan. Helping our customers to obtain increased value from electron microscopy in conjunction with and complementary to XRD and NMR is a key element of that plan.”

Related Links:

FEI
National Institutes of Health


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Sulfidoleukotrienes (sLT) Assay
CAST ELISA
New
Automated Cell Counter
QuadCount

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.